E-LIB Suche - Ergebnisse für: Schlessinger, Joel

1

Efficacy and Safety of Ruxolitinib Cream Among Children Wit..:

Soong, Weily ; Zaenglein, Andrea ; Tollefson, Megha...
Journal of Allergy and Clinical Immunology. 153 (2024) 2 - p. AB1 , 2024

Link: https://doi.org/10.1016/..

2

Efficacy and Safety of a Novel Formulation Liquid Botulinum..:

Bertucci, Vince ; Schlessinger, Joel ; Joseph, John...
Toxicon. 237 (2024) - p. 107369 , 2024

Link: https://doi.org/10.1016/..

3

Millennial Subject Satisfaction With Two Treatments of Abob..:

Cohen, Joel L. ; Jacob, Carolyn ; Schlessinger, Joel..
Toxicon. 214 (2022) - p. S11 , 2022

Link: https://doi.org/10.1016/..

4

Collagenase Clostridium Histolyticum-aaes for Treatment of ..:

Bass, Lawrence S. ; Kaufman-Janette, Joely ; Joseph, John H....
Plastic and Reconstructive Surgery - Global Open. 10 (2022) 5 - p. e4306 , 2022

Link: https://doi.org/10.1097/..

5

Subject-Relevant Outcomes of On-Label 50 U Abobotulinumtoxi..:

Moradi, Amir ; Cox, Sue Ellen ; Glaser, Dee Anna...
Toxicon. 214 (2022) - p. S42 , 2022

Link: https://doi.org/10.1016/..

6

33499 Subject-relevant outcomes of on-label 50U abobotulinu..:

Glaser, Dee Anna ; Cox, Sue Ellen ; Moradi, Amir...
Journal of the American Academy of Dermatology. 87 (2022) 3 - p. AB205 , 2022

Link: https://doi.org/10.1016/..

7

Collagenase Clostridium Histolyticum-aaes for the Treatment..:

Kaufman-Janette, Joely ; Joseph, John H. ; Kaminer, Michael S....
Dermatologic Surgery. 47 (2021) 5 - p. 649-656 , 2021

Link: https://doi.org/10.1097/..

8

Corrigendum to: The Second of Two One-Year, Multicenter, Op..:

Lorenc, Z Paul ; Adelglass, Jeffrey M ; Avelar, Rui L...
Aesthetic Surgery Journal. 41 (2021) 12 - p. 1494-1495 , 2021

Link: https://doi.org/10.1093/..

9

Corrigendum to: The First of Two One-Year, Multicenter, Ope..:

Kaufman-Janette, Joely ; Avelar, Rui L ; Biesman, Brian S...
Aesthetic Surgery Journal. 41 (2021) 12 - p. 1494-1494 , 2021

Link: https://doi.org/10.1093/..

10

26993 Efficacy and safety of crisaborole by body region in ..:

Schlessinger, Joel ; Shepard, Julie S. ; Forsha, Douglass W....
Journal of the American Academy of Dermatology. 85 (2021) 3 - p. AB125 , 2021

Link: https://doi.org/10.1016/..

11

The First of Two One-Year, Multicenter, Open-Label, Repeat-..:

Kaufman-Janette, Joely ; Avelar, Rui L ; Biesman, Brian S...
Aesthetic Surgery Journal. 41 (2021) 12 - p. 1409-1422 , 2021

Link: https://doi.org/10.1093/..

12

Efficacy and Safety of a New Resilient Hyaluronic Acid Fill..:

Sundaram, Hema ; Shamban, Ava ; Schlessinger, Joel...
Dermatologic Surgery. 48 (2021) 1 - p. 87-93 , 2021

Link: https://doi.org/10.1097/..

13

The Second of Two One-Year, Multicenter, Open-Label, Repeat..:

Lorenc, Z Paul ; Adelglass, Jeffrey M ; Avelar, Rui L...
Aesthetic Surgery Journal. 41 (2021) 12 - p. 1423-1438 , 2021

Link: https://doi.org/10.1093/..

14

A phase II, randomized, double‐blind, placebo‐controlled, d..:

Elewski, B. ; Brand, S. ; Degenhardt, T....
British Journal of Dermatology. 184 (2020) 2 - p. 270-280 , 2020

Link: https://doi.org/10.1111/..

15

Safety, Effectiveness, and Pharmacokinetics of Crisaborole ..:

Schlessinger, Joel ; Shepard, Julie S. ; Gower, Richard...
American Journal of Clinical Dermatology. 21 (2020) 2 - p. 275-284 , 2020

Link: https://doi.org/10.1007/..